| (Values in U.S. Thousands) | Jul, 2020 | Jul, 2019 | Jul, 2018 | Jul, 2017 | Jul, 2016 |
| Sales | 2,660 | 6,200 | 700 | 0 | 0 |
| Sales Growth | -57.10% | +785.71% | unch | unch | unch |
| Net Income | -33,340 | -9,340 | 36,330 | -70,020 | -3,220 |
| Net Income Growth | -256.96% | -125.71% | +151.89% | -2,074.53% | unch |
Generex Biotechnology Corp (GNBTQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Generex Biotechnology Corporation provides research, development, and commercialization of drug delivery systems and technologies. The company's products include Generex Oral-lyn, Glucose RapidSpray, BaBOOM Energy Spray and Crave-NX. It markets its products primarily in Ecuador, Canada, and the United States. Generex Biotechnology Corporation is based in Toronto, Canada.
Fiscal Year End Date: 07/31